Associate Professor, Surgery, Cleveland Clinic Lerner College of Medicine at Case Western Reserve University
Colon & Rectal Surgery
Dr. Matthew F. Kalady, MD
|
|
Give Review
Matthew Kalady works in the field of Colon & Rectal Surgery. He graduated from Duke University School of Medicine. Duke University School of Medicine is a top medical university. Duke University School of Medicine is ranked 8 in research and 29 in primary care medicine He has 3 awards "Regional Top Doctor", "CMS Meaningful Use Stage 1 Certification" and "Fellow (FACS)". Doctor Matthew F. Kalady, MD is also published. He has 101 publications published. The lastest publication: "Decreased fibrinolytic activity in porcine-to-primate cardiac xenotransplantation.' Matthew Kalady accepts Medicare payments and is listed with Medicare.gov.
Publications
- Mutation Spectrum and Risk of ColoRectal Cancer in African American Families with Lynch Syndrome.
- Defining the adenoma burden in lynch syndrome.
- Desmoids and genotype in familial adenomatous polyposis.
- Radiation therapy in patients with inflammatory bowel disease and coloRectal cancer: Risks and benefits.
- Characteristics of benign and malignant thyroid Disease in familial adenomatous polyposis patients and recommendations for Disease surveillance.
- Assessment of a novel, full-thickness incisional biopsy model to restage Rectal tumours after neoadjuvant chemoradiotherapy: results of an ex vivo pilot study.
- Restorative proctocolectomy with a handsewn IPAA: S-pouch or J-pouch?
- Transcriptional profiles underpin microsatellite status and associated features in colon Cancer.
- Integrating Systemic and Surgical Approaches to Treating Metastatic ColoRectal Cancer.
- American joint committee on cancer and college of american pathologists regression grade: a new prognostic factor in Rectal cancer.
- Genotype-defined Cancer risk in juvenile polyposis syndrome.
- Prophylactic colectomy: Rationale, indications, and approach.
- Laparoscopy mitigates adverse oncological effects of delayed adjuvant chemotherapy for colon Cancer.
- Glioma Cancer stem cells secrete Gremlin1 to promote their maintenance within the tumor hierarchy.
- Defining HNPCC and Lynch syndrome: what's in a name?
- Does reevaluation of coloRectal cancers with inadequate nodal yield lead to stage migration or the identification of metastatic lymph nodes?
- Immunohistochemistry for Annexin A10 Can Distinguish Sporadic From Lynch Syndrome-associated Microsatellite-unstable ColoRectal Carcinoma.
- Clinical criteria underestimate complete pathological response in Rectal cancer treated with neoadjuvant chemoradiotherapy.
- Desmoid tumors do not prevent proctectomy following abdominal colectomy and ileoRectal anastomosis in patients with familial adenomatous polyposis.
- Gene expression profile is associated with chemoradiation resistance in Rectal cancer.
- Metachronous serrated neoplasia is uncommon after right colectomy in patients with methylator colon Cancers with a high degree of microsatellite instability.
- Sessile serrated polyps: an important route to coloRectal cancer.
- Prevalence of occult gynecologic malignancy at the time of risk reducing and nonprophylactic surgery in patients with Lynch syndrome.
- Statin Therapy Is Associated With Improved Pathologic Response to Neoadjuvant Chemoradiation in Rectal Cancer.
- Consensus transcriptomic profiles can be utilised to differentiate node negative and node positive coloRectal cancer.
- Introducing a Novel and Robust Technique for Determining Lymph Node Status in ColoRectal Cancer.
- Anal transitional zone neoplasia in patients with familial adenomatous polyposis after restorative proctocolectomy and IPAA: incidence, management, and oncologic and f...
- Results from an American Society of Colon and Rectal Surgeons survey on the management of young-onset coloRectal cancer.
- Less Than 12 Nodes in the Surgical Specimen After Total MesoRectal Excision Following Neoadjuvant Chemoradiation: It means more than you think!
- Impact of Obesity on Operation Performed, Complications, and Long-term Outcomes in Terms of Restoration of Intestinal Continuity for Patients With Mid and Low Rectal C...
- Snaring large serrated polyps.
- Importance of serrated polyps in coloRectal carcinogenesis.
- Implementation of universal microsatellite instability and immunohistochemistry screening for diagnosing lynch syndrome in a large academic medical center.
- Risk factors for delayed postpolypectomy bleeding: how to minimize your patients' risk.
- Multiplex flow cytometry barcoding and antibody arrays identify surface antigen profiles of primary and metastatic colon Cancer cell lines.
- Serrated polyp detection rate during screening colonoscopy.
- The prevalence of hereditary hemorrhagic telangiectasia in juvenile polyposis syndrome.
- Risk of colonic neoplasia after proctectomy for Rectal cancer in hereditary nonpolyposis coloRectal cancer.
- High-throughput arrays identify distinct genetic profiles associated with lymph node involvement in Rectal cancer.
- BRAF Mutations in ColoRectal Cancer Are Associated With Distinct Clinical Characteristics and Worse Prognosis.
- Plasma soluble vascular adhesion molecule-1 levels are persistently elevated during the first month after coloRectal cancer resection.
- Plasma from the second and third weeks after open coloRectal resection for cancer stimulates in vitro endothelial cell growth, migration, and invasion.
- Unique DNA methylome profiles in CpG island methylator phenotype colon Cancers.
- Is Adjuvant Chemotherapy Really Needed After Curative Surgery for Rectal Cancer Patients Who are Node-Negative After Neoadjuvant Chemoradiotherapy?
- Prone or lithotomy positioning during an abdominoperineal resection for Rectal cancer results in comparable oncologic outcomes.
- Pathologic complete response after neoadjuvant treatment for Rectal cancer decreases distant recurrence and could eradicate local recurrence.
- Relative role of methylator and tumor suppressor pathways in ulcerative colitis-associated colon Cancer.
- Minimally Invasive ColoRectal Resection Is Associated With a Transient Increase in Plasma Hepatocyte Growth Factor Levels Early After Surgery for Colon Cancer.
- Response to Letter to the Editor: Neoadjuvant Therapy for Rectal Cancer: The Impact of Longer Interval Between Chemoradiation and Surgery.
- Neoadjuvant therapy for Rectal cancer: the impact of longer interval between chemoradiation and surgery.
- Hand-assisted laparoscopic right colectomy: how does it compare to conventional laparoscopy?
- Defining phenotypes and Cancer risk in hyperplastic polyposis syndrome.
- Surgical management of hereditary nonpolyposis coloRectal cancer.
- Minimally invasive colon resection is associated with a persistent increase in plasma PlGF levels following Cancer resection.
- Clinical implications of acellular mucin pools in resected Rectal cancer with pathological complete response to neoadjuvant chemoradiation.
- Plasma levels of angiostatin and endostatin remain unchanged for the first 3 weeks after coloRectal cancer surgery.
- Risk of coloRectal adenoma and carcinoma after colectomy for coloRectal cancer in patients meeting Amsterdam criteria.
- Gene signature is associated with early stage Rectal cancer recurrence.
- Downstaging without complete pathologic response after neoadjuvant treatment improves cancer outcomes for cIII but not cII Rectal cancers.
- Surgeon involvement in preoperative coloRectal tumor localization.
- CEACAM-7: a predictive marker for Rectal cancer recurrence.
- Stage III coloRectal cancer: molecular disparity between primary cancers and lymph node metastases.
- Anal neoplasms.
- Is the phenotype mixed or mistaken? Hereditary nonpolyposis coloRectal cancer and hyperplastic polyposis syndrome.
- Predictive factors of pathologic complete response after neoadjuvant chemoradiation for Rectal cancer.
- Identification of the methylator (serrated) coloRectal cancer phenotype through precursor serrated polyps.
- Genetic and molecular diversity of colon Cancer hepatic metastases.
- Divergent oncogenic changes influence survival differences between colon and Rectal adenocarcinomas.
- Identifying Lynch syndrome: we are all responsible.
- Routine contrast imaging of low pelvic anastomosis prior to closure of defunctioning ileostomy: is it necessary?
- Cotransfection of DC with TLR4 and MART-1 RNA induces MART-1-specific responses.
- Pancreatic duct strictures: identifying risk of malignancy.
- Dendritic cells pulsed with pancreatic Cancer total tumor RNA generate specific antipancreatic Cancer T cells.
- Sequential delivery of maturation stimuli increases human dendritic cell IL-12 production and enhances tumor antigen-specific immunogenicity.
- Thin melanomas: predictive lethal characteristics from a 30-year clinical experience.
- CD40 ligand is essential for generation of specific cytotoxic T cell responses in RNA-pulsed dendritic cell immunotherapy.
- Induction of anti-melanoma CTL response using DC transfected with mutated mRNA encoding full-length Melan-A/MART-1 antigen with an A27L amino acid substitution.
- Loop ileostomy closure at an ambulatory surgery facility: a safe and cost-effective alternative to routine hospitalization.
- Clinical practice. Suspected Appendicitis.
- Clinical utility of positron emission tomography in the diagnosis and management of periampullary neoplasms.
- Dendritic cell gene therapy.
- Enhanced dendritic cell antigen presentation in RNA-based immunotherapy.
- Poor outcome and quality of life in female patients undergoing secondary surgery for recurrent peptic ulcer Disease.
- Pancreas-preserving duodenectomy in the management of duodenal familial adenomatous polyposis.
- Fever evaluations after coloRectal surgery: identification of risk factors that increase yield and decrease cost.
- Validation of delayed sentinel lymph node mapping for melanoma.
- Immediate and long-term outcomes after lateral pancreaticojejunostomy for chronic pancreatitis.
- Decreased fibrinolytic activity in porcine-to-primate cardiac xenotransplantation.
- Laparoscopic adrenalectomy for pheochromocytoma. A comparison to aldosteronoma and incidentaloma.
- Identification of a human rasGAP-related protein containing calmodulin-binding motifs.
- Minimally invasive colon resection is associated with a transient increase in plasma sVEGFR1 levels and a decrease in sVEGFR2 levels during the early postoperative per...
- Minimally invasive colon resection for malignant colonic conditions is associated with a transient early increase in plasma sVEGFR1 and a decrease in sVEGFR2 levels af...
- Genetic and epigenetic classifications define clinical phenotypes and determine patient outcomes in coloRectal cancer.
- A novel method for determining microflora composition using dynamic phylogenetic Analysis of 16S ribosomal RNA deep sequencing data.
- Familial coloRectal cancer type X: polyp burden and cancer risk stratification via a family history score.
- BRAF testing in advanced coloRectal cancer: is it ready for prime time?
- Minimally invasive coloRectal resection for cancer is associated with a short-lived decrease in soluble Tie-2 receptor levels, which may transiently inhibit VEGF-media...
- Minimally invasive coloRectal resection is associated with a rapid and sustained decrease in plasma levels of epidermal growth factor (EGF) in the colon cancer setting.
- Laparoscopic colectomy is safe and leads to a significantly shorter hospital stay for octogenarians.
- ColoRectal resection is associated with persistent proangiogenic plasma protein changes: postoperative plasma stimulates in vitro endothelial cell growth, migration, a...
Schools
Duke University School Of Medicine
Procedures Preformed
- Anoscopy With Removal of Anal Tumor
- Appendectomy, Laparoscopic
- Appendectomy, Open
- Colectomy
- View All
Conditions Treated
- Anal and Rectal Cancer
- Anal Fissure
- Anal Fistula
- AnoRectal Abscess
- View All
Doctors Specialties
- General Surgery
Accepted Insurances
Awards
- Regional Top Doctor
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACS)
Education
-
Cleveland Clinic Foundation -
Duke University Hospital -
Duke University School of Medicine
Hospital
-
Cleveland Clinic
Drug Facts
| NPI NUMBER | 1639180003 | |
| NPPES Provider LastName | KALADY | |
| NPPES Provider FirstName | MATTHEW | |
| NPPES Provider ZIPCode | 441950001 | |
| NPPES Provider State | OH | |
| Specialty Description | Colorectal Surgery (formerly proctology) | |
| Total Claim Count | 46.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1639180003 |
| Last Name Of The Provider | KALADY |
| First Name Of The Provider | MATTHEW |
| View All |
Similar Doctors
|
|
Dr. Jon D. Vogel, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Jeremy M. Lipman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Henry W. Eisenberg, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Conor P. Delaney, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David W. Dietz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Myles R. Joyce, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hermann Kessler, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elizabeth A. Myers, DO |
|
|
Dr. Hahn Soe-Lin, MD |
|
|
Dr. Matthias Turina, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Sricharan Chalikonda, MB
This Doctor is OpenDoctor Recommended.
|